Fundraising FoxClearPoint Neuro
NASDAQ: CLPTSolana Beach, US · 1 known investors
Find your way into ClearPoint Neuro
454 people in our graph share verified history with the ClearPoint Neuro team — schools, employers, funds. One of them is your warm intro.
Nikki Schwenkunlockedknows Danilo D'Alessandro · together at ClearPoint Neuro, Inc. (overlapped)
×11knows the team · via Coopers & Lybrand
ClearPoint Neuro develops neurosurgical guidance systems and platforms that enable precise navigation to the brain and spine for device, cell, and gene therapy procedures. The company serves neurosurgery centers and supports clinical drug delivery trials through live MRI-guided and image-guided technology.
Founders & leadership
DD
Danilo D'AlessandroExecutiveDanilo D'Alessandro served as CFO of Philips Image Guided Therapy Devices, overseeing finance and accounting operations for a $900+ million global business spanning cardiovascular medical devices. He brings over 12 years of international finance leadership experience, including M&A execution and operational streamlining across multiple organizations.
JM
Joseph M. BurnettExecutive
JL
Jenkins L. KimbleExecutive
RC
Robert C. KornVice President, Sales
FP
Francis P. GrilloChief Executive Officer and President
HA
Harold A. HurwitzChief Operating Officer and Corporate Secretary
DW
David W. CarlsonChief Financial OfficerDavid W. Carlson is Chief Financial Officer at ClearPoint Neuro, a developer of neurosurgical guidance systems for brain and spine procedures. He brings finance and operations experience including strategic planning, process improvement, and team leadership in growing organizations.
Board
RJ
R. John FletcherBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$63.9M disclosed across 7 rounds · 2014–2025
▶$17.9MraisedFeb 2026 · 46 investors · BiotechnologyRule 506(b)
▶$17.9MraisedFeb 2026 · 46 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Danilo D'AlessandroExecutive Officer
- Matthew B. KleinDirector
- Timothy T. RichardsDirector
- Mazin SabraExecutive Officer
- Jeremy L. StigallExecutive Officer
- R. John FletcherDirector
- Linda M. LiauDirector
- Pascal E.R. GirinDirector
- Lynnette C. FallonDirector
- Joseph M. BurnettExecutive Officer, Director
- B. Kristine JohnsonDirector
- Offering amount
- $17.9M
- Amount sold
- $17.9M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedMay 2019 · 17 investors · Other Health CareRule 506(b)
▶$7.5MraisedMay 2019 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- R. John FletcherDirector
- Pascal E.R. GirinDirector
- Timothy RichardsDirector
- John N. Spencer, Jr.Director
- Marcio SouzaDirector
- Kimble L. JenkinsDirector
- Harold A. HurwitzExecutive Officer
- Peter G. PiferiExecutive Officer
- Joseph M. BurnettExecutive Officer, Director
- Offering amount
- $7.5M
- Amount sold
- $7.5M
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedJun 2017 · 60 investors · Other Health CareRule 506(b)
▶$13.3MraisedJun 2017 · 60 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter G. PiferiExecutive Officer
- Maria SainzDirector
- Charles E. KoobDirector
- Kimble L. JenkinsDirector
- Wendelin ManersExecutive Officer
- Pascal E.R. GirinDirector
- Francis P. GrilloExecutive Officer, Director
- Timothy T. RichardsDirector
- Harold A. HurwitzExecutive Officer
- Philip A. Pizzo, M.D.Director
- John N. Spencer, Jr.Director
- R. John FletcherDirector
- Offering amount
- $13.3M
- Amount sold
- $13.3M
- Sales commissions
- $1M
- Placement agents
- Joseph Gunnar & Co., LLC, CIM Securities, LLC
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedSep 2016 · 24 investors · Other Health CareRule 506(b)
▶$6MraisedSep 2016 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kimble L. JenkinsDirector
- Robert C. KornExecutive Officer
- Peter G. PiferiExecutive Officer
- Maria SainzDirector
- Philip A. Pizzo, M.D.Director
- Francis P. GrilloExecutive Officer, Director
- John N. Spencer, Jr.Director
- Wendelin ManersExecutive Officer
- Pascal E.R. GirinDirector
- Harold A. HurwitzExecutive Officer
- Timothy T. RichardsDirector
- Charles E. KoobDirector
- Andrew K. RookeDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Sales commissions
- $196.5K
- Placement agents
- Alexander Capital, L.P., CIM Securities, LLC
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.3MraisedDec 2015 · 57 investors · Other Health CareRule 506(b)
▶$5.3MraisedDec 2015 · 57 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jenkins L. KimbleExecutive Officer, Director
- Timothy T. RichardsDirector
- Philip A. Pizzo, M.D.Director
- Robert C. KornExecutive Officer
- Maria SainzDirector
- Francis P. GrilloExecutive Officer, Director
- Pascal E.R. GirinDirector
- Harold A. HurwitzExecutive Officer
- John N. Spencer, Jr.Director
- Charles E. KoobDirector
- Andrew K. RookeDirector
- Offering amount
- $5.3M
- Amount sold
- $5.3M
- Sales commissions
- $380.2K
- Placement agents
- Alexander Capital, L.P., Brookline Group, LLC
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.2MraisedDec 2014 · 74 investors · Other Health CareRule 506(b)
▶$10.2MraisedDec 2014 · 74 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Francis P. GrilloExecutive Officer
- Jenkins L. KimbleExecutive Officer, Director
- Philip A. Pizzo, M.D.Director
- Charles E. KoobDirector
- Pascal E.R. GirinDirector
- Andrew K. RookeDirector
- Michael J. RyanDirector
- Peter G. PiferiExecutive Officer
- David W. CarlsonExecutive Officer
- Timothy T. RichardsDirector
- Oscar L. ThomasExecutive Officer
- Robert C. KornExecutive Officer
- John N. Spencer, Jr.Director
- Maria SainzDirector
- Wendelin ManersExecutive Officer
- Offering amount
- $10.2M
- Amount sold
- $10.2M
- Sales commissions
- $712.3K
- Placement agents
- Newport Coast Securities, Inc., Brookline Group, LLC, Clark Dodge & Co., Inc.
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.7MraisedApr 2014 · 10 investors · Other Health CareRule 506(b)
▶$3.7MraisedApr 2014 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy T. RichardsDirector
- Kimble L. JenkinsExecutive Officer, Director
- Michael J. RyanDirector
- Robert C. KornExecutive Officer
- Philip A. Pizzo, M.D.Director
- Andrew K. RookeDirector
- Peter G. PiferiExecutive Officer
- John N. Spencer, Jr.Director
- David W. CarlsonExecutive Officer
- Maria SainzDirector
- Charles E. KoobDirector
- Michael A. PietrangeloDirector
- Oscar L. Thomas, Jr.Executive Officer
- Offering amount
- $3.7M
- Amount sold
- $3.7M
- Sales commissions
- $145.5K
- Placement agents
- Brookline Group, LLC, Gilford Securities Incorporated
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Valuation · disclosed
Disclosed events$29.8Mvaluation at IPOAug 2016 · $6.75/share · S-1/A
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Related companies · 3
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
GenhealthGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies working in the same space as ClearPoint Neuro.
Frequently asked questions
- What does ClearPoint Neuro do?
- ClearPoint Neuro develops neurosurgical guidance systems and platforms that enable precise navigation to the brain and spine for device, cell, and gene therapy procedures. The company serves neurosurgery centers and supports clinical drug delivery trials through live MRI-guided and image-guided technology.
- Who are ClearPoint Neuro's investors?
- ClearPoint Neuro's investors include Oberland Capital.
- How much funding has ClearPoint Neuro raised?
- ClearPoint Neuro has disclosed $63.9M raised across 7 rounds.
- Where is ClearPoint Neuro headquartered?
- ClearPoint Neuro is headquartered in Solana Beach, US.